Clinical Trial Update: FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of Fecal Microbiota Transplant (FMT) with an immune checkpoint inhibitor and a tyrosine kinase inhibitor in advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms Malignant

Drugs mentioned

• FMT (fecal microbiota transplant) (Fecal microbiota transplant)
• Immune checkpoint inhibitor
• Tyrosine Kinase Inhibitor

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Colorectal Neoplasms Malignant | Phase 2 | Status: UNKNOWN